nodes	percent_of_prediction	percent_of_DWPC	metapath
Liothyronine—SLC7A5—Melphalan—hematologic cancer	0.178	0.457	CbGbCtD
Liothyronine—L-Tyrosine—Melphalan—hematologic cancer	0.136	0.469	CrCrCtD
Liothyronine—L-DOPA—Melphalan—hematologic cancer	0.0966	0.332	CrCrCtD
Liothyronine—ALB—hematologic cancer	0.0618	0.512	CbGaD
Liothyronine—ABCB1—hematologic cancer	0.059	0.488	CbGaD
Liothyronine—L-Phenylalanine—Melphalan—hematologic cancer	0.0578	0.199	CrCrCtD
Liothyronine—SLCO1A2—Chlorambucil—hematologic cancer	0.027	0.0691	CbGbCtD
Liothyronine—SLCO4C1—Methotrexate—hematologic cancer	0.02	0.0512	CbGbCtD
Liothyronine—SLCO1C1—Methotrexate—hematologic cancer	0.014	0.0359	CbGbCtD
Liothyronine—SLC22A8—Mercaptopurine—hematologic cancer	0.0129	0.033	CbGbCtD
Liothyronine—SLCO1A2—Prednisolone—hematologic cancer	0.0102	0.0261	CbGbCtD
Liothyronine—SLCO1A2—Prednisone—hematologic cancer	0.00964	0.0247	CbGbCtD
Liothyronine—ABCB1—Lenalidomide—hematologic cancer	0.00881	0.0225	CbGbCtD
Liothyronine—SLCO1B1—Irinotecan—hematologic cancer	0.00862	0.0221	CbGbCtD
Liothyronine—SLCO1B3—Methotrexate—hematologic cancer	0.00783	0.0201	CbGbCtD
Liothyronine—ALB—Imatinib—hematologic cancer	0.00756	0.0194	CbGbCtD
Liothyronine—SLCO1A2—Dexamethasone—hematologic cancer	0.00602	0.0154	CbGbCtD
Liothyronine—ABCB1—Daunorubicin—hematologic cancer	0.00516	0.0132	CbGbCtD
Liothyronine—ABCB1—Alitretinoin—hematologic cancer	0.00506	0.0129	CbGbCtD
Liothyronine—ALB—Prednisone—hematologic cancer	0.00498	0.0128	CbGbCtD
Liothyronine—SLCO1A2—Methotrexate—hematologic cancer	0.00484	0.0124	CbGbCtD
Liothyronine—ALB—Irinotecan—hematologic cancer	0.00472	0.0121	CbGbCtD
Liothyronine—SLCO1B1—Methotrexate—hematologic cancer	0.00456	0.0117	CbGbCtD
Liothyronine—SLC22A8—Methotrexate—hematologic cancer	0.00421	0.0108	CbGbCtD
Liothyronine—ABCB1—Imatinib—hematologic cancer	0.00395	0.0101	CbGbCtD
Liothyronine—ABCB1—Nilotinib—hematologic cancer	0.00359	0.0092	CbGbCtD
Liothyronine—ABCB1—Vinorelbine—hematologic cancer	0.00356	0.00912	CbGbCtD
Liothyronine—ABCB1—Dasatinib—hematologic cancer	0.00318	0.00813	CbGbCtD
Liothyronine—ABCB1—Mitoxantrone—hematologic cancer	0.00314	0.00803	CbGbCtD
Liothyronine—ABCB1—Betamethasone—hematologic cancer	0.0028	0.00716	CbGbCtD
Liothyronine—ABCB1—Gemcitabine—hematologic cancer	0.00277	0.00709	CbGbCtD
Liothyronine—ABCB1—Prednisolone—hematologic cancer	0.00276	0.00706	CbGbCtD
Liothyronine—ABCB1—Prednisone—hematologic cancer	0.00261	0.00667	CbGbCtD
Liothyronine—ALB—Methotrexate—hematologic cancer	0.0025	0.0064	CbGbCtD
Liothyronine—SERPINA7—hematopoietic system—hematologic cancer	0.00249	0.062	CbGeAlD
Liothyronine—ABCB1—Irinotecan—hematologic cancer	0.00247	0.00632	CbGbCtD
Liothyronine—ABCB1—Vinblastine—hematologic cancer	0.0022	0.00562	CbGbCtD
Liothyronine—ABCB1—Vincristine—hematologic cancer	0.00216	0.00553	CbGbCtD
Liothyronine—ABCB1—Cisplatin—hematologic cancer	0.00201	0.00515	CbGbCtD
Liothyronine—ABCB1—Etoposide—hematologic cancer	0.00198	0.00506	CbGbCtD
Liothyronine—L-DOPA—PSIP1—hematologic cancer	0.00172	0.783	CrCbGaD
Liothyronine—SERPINA7—blood—hematologic cancer	0.00165	0.0411	CbGeAlD
Liothyronine—ABCB1—Dexamethasone—hematologic cancer	0.00163	0.00416	CbGbCtD
Liothyronine—SERPINA7—bone marrow—hematologic cancer	0.0016	0.0398	CbGeAlD
Liothyronine—ABCB1—Doxorubicin—hematologic cancer	0.00135	0.00345	CbGbCtD
Liothyronine—ABCB1—Methotrexate—hematologic cancer	0.00131	0.00335	CbGbCtD
Liothyronine—SLC7A5—hematopoietic system—hematologic cancer	0.00117	0.0292	CbGeAlD
Liothyronine—THRB—gonad—hematologic cancer	0.00117	0.0291	CbGeAlD
Liothyronine—THRA—gonad—hematologic cancer	0.00117	0.0291	CbGeAlD
Liothyronine—TTR—hematopoietic system—hematologic cancer	0.00114	0.0285	CbGeAlD
Liothyronine—SLCO4C1—blood—hematologic cancer	0.00106	0.0265	CbGeAlD
Liothyronine—SLC10A1—gonad—hematologic cancer	0.00103	0.0258	CbGeAlD
Liothyronine—SLCO4C1—bone marrow—hematologic cancer	0.00103	0.0256	CbGeAlD
Liothyronine—SLCO4C1—lung—hematologic cancer	0.000931	0.0232	CbGeAlD
Liothyronine—SLCO1B3—lung—hematologic cancer	0.000905	0.0226	CbGeAlD
Liothyronine—SLCO1B1—hematopoietic system—hematologic cancer	0.000901	0.0225	CbGeAlD
Liothyronine—SLC16A10—hematopoietic system—hematologic cancer	0.000898	0.0224	CbGeAlD
Liothyronine—THRB—lung—hematologic cancer	0.000893	0.0223	CbGeAlD
Liothyronine—THRA—lung—hematologic cancer	0.000893	0.0223	CbGeAlD
Liothyronine—SLC7A5—gonad—hematologic cancer	0.000892	0.0222	CbGeAlD
Liothyronine—THRB—testis—hematologic cancer	0.000843	0.021	CbGeAlD
Liothyronine—THRA—testis—hematologic cancer	0.000843	0.021	CbGeAlD
Liothyronine—SLC7A5—blood—hematologic cancer	0.000777	0.0194	CbGeAlD
Liothyronine—TTR—blood—hematologic cancer	0.000757	0.0189	CbGeAlD
Liothyronine—SLC7A5—Isotretinoin—Alitretinoin—hematologic cancer	0.000753	0.376	CbGdCrCtD
Liothyronine—SLC7A5—Tretinoin—Alitretinoin—hematologic cancer	0.000753	0.376	CbGdCrCtD
Liothyronine—SLC7A5—bone marrow—hematologic cancer	0.000752	0.0187	CbGeAlD
Liothyronine—SLC10A1—testis—hematologic cancer	0.000745	0.0186	CbGeAlD
Liothyronine—SLCO1A2—hematopoietic system—hematologic cancer	0.000734	0.0183	CbGeAlD
Liothyronine—TTR—bone marrow—hematologic cancer	0.000733	0.0183	CbGeAlD
Liothyronine—SLCO1C1—testis—hematologic cancer	0.0007	0.0175	CbGeAlD
Liothyronine—SLC22A8—hematopoietic system—hematologic cancer	0.0007	0.0175	CbGeAlD
Liothyronine—SLC16A10—gonad—hematologic cancer	0.000683	0.017	CbGeAlD
Liothyronine—SLC7A5—lung—hematologic cancer	0.000681	0.017	CbGeAlD
Liothyronine—TTR—lung—hematologic cancer	0.000664	0.0165	CbGeAlD
Liothyronine—SLC7A5—testis—hematologic cancer	0.000643	0.016	CbGeAlD
Liothyronine—TTR—testis—hematologic cancer	0.000626	0.0156	CbGeAlD
Liothyronine—THRB—lymph node—hematologic cancer	0.000611	0.0152	CbGeAlD
Liothyronine—THRA—lymph node—hematologic cancer	0.000611	0.0152	CbGeAlD
Liothyronine—SLCO1B1—blood—hematologic cancer	0.000597	0.0149	CbGeAlD
Liothyronine—SLC16A10—blood—hematologic cancer	0.000595	0.0148	CbGeAlD
Liothyronine—SLCO4A1—lung—hematologic cancer	0.000595	0.0148	CbGeAlD
Liothyronine—SLCO4A1—testis—hematologic cancer	0.000561	0.014	CbGeAlD
Liothyronine—SLC16A10—lung—hematologic cancer	0.000522	0.013	CbGeAlD
Liothyronine—SLCO1C1—lymph node—hematologic cancer	0.000508	0.0127	CbGeAlD
Liothyronine—SLC16A10—testis—hematologic cancer	0.000492	0.0123	CbGeAlD
Liothyronine—SLC7A5—lymph node—hematologic cancer	0.000466	0.0116	CbGeAlD
Liothyronine—SLC22A8—blood—hematologic cancer	0.000464	0.0116	CbGeAlD
Liothyronine—SLCO1A2—lung—hematologic cancer	0.000426	0.0106	CbGeAlD
Liothyronine—Cardiac failure congestive—Bortezomib—hematologic cancer	0.000425	0.00536	CcSEcCtD
Liothyronine—Arrhythmia—Methoxsalen—hematologic cancer	0.00041	0.00517	CcSEcCtD
Liothyronine—Angina pectoris—Nilotinib—hematologic cancer	0.000407	0.00514	CcSEcCtD
Liothyronine—SLCO4A1—lymph node—hematologic cancer	0.000407	0.0101	CbGeAlD
Liothyronine—Angina pectoris—Imatinib—hematologic cancer	0.000405	0.00511	CcSEcCtD
Liothyronine—SLCO1A2—testis—hematologic cancer	0.000402	0.01	CbGeAlD
Liothyronine—ALB—testis—hematologic cancer	0.0004	0.00996	CbGeAlD
Liothyronine—Acute coronary syndrome—Dasatinib—hematologic cancer	0.000398	0.00502	CcSEcCtD
Liothyronine—Acute coronary syndrome—Fludarabine—hematologic cancer	0.000396	0.005	CcSEcCtD
Liothyronine—Myocardial infarction—Dasatinib—hematologic cancer	0.000395	0.00499	CcSEcCtD
Liothyronine—Myocardial infarction—Fludarabine—hematologic cancer	0.000394	0.00497	CcSEcCtD
Liothyronine—Arrhythmia—Daunorubicin—hematologic cancer	0.000393	0.00496	CcSEcCtD
Liothyronine—Arrhythmia—Pentostatin—hematologic cancer	0.000391	0.00493	CcSEcCtD
Liothyronine—Arrhythmia—Anagrelide—hematologic cancer	0.000391	0.00493	CcSEcCtD
Liothyronine—Phlebitis—Carmustine—hematologic cancer	0.000388	0.00489	CcSEcCtD
Liothyronine—Phlebitis—Alitretinoin—hematologic cancer	0.000384	0.00485	CcSEcCtD
Liothyronine—Cardiac failure congestive—Thalidomide—hematologic cancer	0.000384	0.00484	CcSEcCtD
Liothyronine—Angina pectoris—Vinblastine—hematologic cancer	0.000381	0.00481	CcSEcCtD
Liothyronine—Phlebitis—Ifosfamide—hematologic cancer	0.00038	0.00479	CcSEcCtD
Liothyronine—Arrhythmia—Idarubicin—hematologic cancer	0.000377	0.00476	CcSEcCtD
Liothyronine—Acute coronary syndrome—Nilotinib—hematologic cancer	0.000367	0.00463	CcSEcCtD
Liothyronine—Arrhythmia—Teniposide—hematologic cancer	0.000367	0.00463	CcSEcCtD
Liothyronine—Myocardial infarction—Nilotinib—hematologic cancer	0.000365	0.00461	CcSEcCtD
Liothyronine—Acute coronary syndrome—Imatinib—hematologic cancer	0.000365	0.00461	CcSEcCtD
Liothyronine—Cardiac failure congestive—Alitretinoin—hematologic cancer	0.000365	0.0046	CcSEcCtD
Liothyronine—Body temperature increased—Vorinostat—hematologic cancer	0.000364	0.0046	CcSEcCtD
Liothyronine—Myocardial infarction—Imatinib—hematologic cancer	0.000363	0.00458	CcSEcCtD
Liothyronine—Phlebitis—Mitoxantrone—hematologic cancer	0.00036	0.00455	CcSEcCtD
Liothyronine—SLC16A10—lymph node—hematologic cancer	0.000357	0.00889	CbGeAlD
Liothyronine—Angina pectoris—Lenalidomide—hematologic cancer	0.000353	0.00445	CcSEcCtD
Liothyronine—Acute coronary syndrome—Vinblastine—hematologic cancer	0.000344	0.00434	CcSEcCtD
Liothyronine—Cardiac failure congestive—Mitoxantrone—hematologic cancer	0.000342	0.00432	CcSEcCtD
Liothyronine—Myocardial infarction—Vinblastine—hematologic cancer	0.000342	0.00432	CcSEcCtD
Liothyronine—Arrhythmia—Busulfan—hematologic cancer	0.00034	0.00429	CcSEcCtD
Liothyronine—Cardiac failure congestive—Gemcitabine—hematologic cancer	0.000334	0.00421	CcSEcCtD
Liothyronine—Hypertension—Clofarabine—hematologic cancer	0.000331	0.00417	CcSEcCtD
Liothyronine—Hypertension—Daunorubicin—hematologic cancer	0.000331	0.00417	CcSEcCtD
Liothyronine—Arrhythmia—Procarbazine—hematologic cancer	0.00033	0.00416	CcSEcCtD
Liothyronine—Hypertension—Pentostatin—hematologic cancer	0.000329	0.00415	CcSEcCtD
Liothyronine—Hypertension—Anagrelide—hematologic cancer	0.000329	0.00415	CcSEcCtD
Liothyronine—Phlebitis—Cisplatin—hematologic cancer	0.000327	0.00413	CcSEcCtD
Liothyronine—Body temperature increased—Lomustine—hematologic cancer	0.000327	0.00412	CcSEcCtD
Liothyronine—Angina pectoris—Bortezomib—hematologic cancer	0.000325	0.0041	CcSEcCtD
Liothyronine—Arrhythmia—Bexarotene—hematologic cancer	0.000323	0.00408	CcSEcCtD
Liothyronine—Arrhythmia—Dasatinib—hematologic cancer	0.000323	0.00408	CcSEcCtD
Liothyronine—Arrhythmia—Fludarabine—hematologic cancer	0.000323	0.00407	CcSEcCtD
Liothyronine—Acute coronary syndrome—Lenalidomide—hematologic cancer	0.000318	0.00402	CcSEcCtD
Liothyronine—Angina pectoris—Vinorelbine—hematologic cancer	0.000317	0.004	CcSEcCtD
Liothyronine—Myocardial infarction—Lenalidomide—hematologic cancer	0.000317	0.00399	CcSEcCtD
Liothyronine—Hypotension—Nelarabine—hematologic cancer	0.000312	0.00394	CcSEcCtD
Liothyronine—Cardiac failure congestive—Cisplatin—hematologic cancer	0.000311	0.00392	CcSEcCtD
Liothyronine—Hypertension—Teniposide—hematologic cancer	0.000309	0.00389	CcSEcCtD
Liothyronine—Tachycardia—Daunorubicin—hematologic cancer	0.000305	0.00385	CcSEcCtD
Liothyronine—Tachycardia—Clofarabine—hematologic cancer	0.000305	0.00385	CcSEcCtD
Liothyronine—Hypotension—Methoxsalen—hematologic cancer	0.000305	0.00385	CcSEcCtD
Liothyronine—Tachycardia—Anagrelide—hematologic cancer	0.000304	0.00383	CcSEcCtD
Liothyronine—Tachycardia—Pentostatin—hematologic cancer	0.000304	0.00383	CcSEcCtD
Liothyronine—Phlebitis—Etoposide—hematologic cancer	0.0003	0.00378	CcSEcCtD
Liothyronine—Arrhythmia—Nilotinib—hematologic cancer	0.000299	0.00377	CcSEcCtD
Liothyronine—Arrhythmia—Imatinib—hematologic cancer	0.000297	0.00375	CcSEcCtD
Liothyronine—Acute coronary syndrome—Bortezomib—hematologic cancer	0.000293	0.0037	CcSEcCtD
Liothyronine—Angina pectoris—Thalidomide—hematologic cancer	0.000293	0.00369	CcSEcCtD
Liothyronine—Hypotension—Clofarabine—hematologic cancer	0.000292	0.00368	CcSEcCtD
Liothyronine—Arrhythmia—Cladribine—hematologic cancer	0.000292	0.00368	CcSEcCtD
Liothyronine—Myocardial infarction—Bortezomib—hematologic cancer	0.000291	0.00367	CcSEcCtD
Liothyronine—Hypotension—Pentostatin—hematologic cancer	0.000291	0.00367	CcSEcCtD
Liothyronine—Hypotension—Anagrelide—hematologic cancer	0.000291	0.00367	CcSEcCtD
Liothyronine—Acute coronary syndrome—Bleomycin—hematologic cancer	0.000291	0.00367	CcSEcCtD
Liothyronine—ALB—lymph node—hematologic cancer	0.00029	0.00722	CbGeAlD
Liothyronine—Myocardial infarction—Bleomycin—hematologic cancer	0.000289	0.00365	CcSEcCtD
Liothyronine—Hypertension—Busulfan—hematologic cancer	0.000286	0.00361	CcSEcCtD
Liothyronine—Acute coronary syndrome—Vinorelbine—hematologic cancer	0.000286	0.00361	CcSEcCtD
Liothyronine—Tachycardia—Teniposide—hematologic cancer	0.000285	0.00359	CcSEcCtD
Liothyronine—Cardiac failure congestive—Etoposide—hematologic cancer	0.000285	0.00359	CcSEcCtD
Liothyronine—Myocardial infarction—Vinorelbine—hematologic cancer	0.000284	0.00359	CcSEcCtD
Liothyronine—Cardiac failure congestive—Prednisolone—hematologic cancer	0.000281	0.00354	CcSEcCtD
Liothyronine—Hypertension—Procarbazine—hematologic cancer	0.000278	0.0035	CcSEcCtD
Liothyronine—Angina pectoris—Ifosfamide—hematologic cancer	0.000275	0.00347	CcSEcCtD
Liothyronine—Hypotension—Teniposide—hematologic cancer	0.000273	0.00344	CcSEcCtD
Liothyronine—Hypertension—Bexarotene—hematologic cancer	0.000272	0.00343	CcSEcCtD
Liothyronine—Hypertension—Dasatinib—hematologic cancer	0.000272	0.00343	CcSEcCtD
Liothyronine—Arrhythmia—Melphalan—hematologic cancer	0.000266	0.00336	CcSEcCtD
Liothyronine—Acute coronary syndrome—Thalidomide—hematologic cancer	0.000264	0.00333	CcSEcCtD
Liothyronine—Tachycardia—Busulfan—hematologic cancer	0.000264	0.00333	CcSEcCtD
Liothyronine—Body temperature increased—Nelarabine—hematologic cancer	0.000264	0.00333	CcSEcCtD
Liothyronine—Myocardial infarction—Thalidomide—hematologic cancer	0.000263	0.00331	CcSEcCtD
Liothyronine—Angina pectoris—Irinotecan—hematologic cancer	0.000261	0.0033	CcSEcCtD
Liothyronine—Arrhythmia—Lenalidomide—hematologic cancer	0.000259	0.00327	CcSEcCtD
Liothyronine—Cardiac failure congestive—Triamcinolone—hematologic cancer	0.000258	0.00326	CcSEcCtD
Liothyronine—Body temperature increased—Methoxsalen—hematologic cancer	0.000258	0.00325	CcSEcCtD
Liothyronine—Tachycardia—Procarbazine—hematologic cancer	0.000256	0.00323	CcSEcCtD
Liothyronine—Hypotension—Busulfan—hematologic cancer	0.000253	0.00319	CcSEcCtD
Liothyronine—Hypertension—Nilotinib—hematologic cancer	0.000251	0.00317	CcSEcCtD
Liothyronine—Acute coronary syndrome—Alitretinoin—hematologic cancer	0.000251	0.00317	CcSEcCtD
Liothyronine—Tachycardia—Dasatinib—hematologic cancer	0.000251	0.00317	CcSEcCtD
Liothyronine—Tachycardia—Bexarotene—hematologic cancer	0.000251	0.00317	CcSEcCtD
Liothyronine—Body temperature increased—Mercaptopurine—hematologic cancer	0.00025	0.00316	CcSEcCtD
Liothyronine—Hypertension—Imatinib—hematologic cancer	0.00025	0.00315	CcSEcCtD
Liothyronine—Myocardial infarction—Alitretinoin—hematologic cancer	0.00025	0.00315	CcSEcCtD
Liothyronine—Acute coronary syndrome—Ifosfamide—hematologic cancer	0.000248	0.00313	CcSEcCtD
Liothyronine—Body temperature increased—Daunorubicin—hematologic cancer	0.000247	0.00312	CcSEcCtD
Liothyronine—Body temperature increased—Clofarabine—hematologic cancer	0.000247	0.00312	CcSEcCtD
Liothyronine—Myocardial infarction—Ifosfamide—hematologic cancer	0.000247	0.00312	CcSEcCtD
Liothyronine—Body temperature increased—Anagrelide—hematologic cancer	0.000246	0.0031	CcSEcCtD
Liothyronine—Body temperature increased—Pentostatin—hematologic cancer	0.000246	0.0031	CcSEcCtD
Liothyronine—ABCB1—hematopoietic system—hematologic cancer	0.000246	0.00612	CbGeAlD
Liothyronine—Hypotension—Procarbazine—hematologic cancer	0.000245	0.00309	CcSEcCtD
Liothyronine—Acute coronary syndrome—Vincristine—hematologic cancer	0.000242	0.00306	CcSEcCtD
Liothyronine—Myocardial infarction—Vincristine—hematologic cancer	0.000241	0.00304	CcSEcCtD
Liothyronine—Hypotension—Dasatinib—hematologic cancer	0.00024	0.00303	CcSEcCtD
Liothyronine—Arrhythmia—Bortezomib—hematologic cancer	0.000238	0.00301	CcSEcCtD
Liothyronine—Body temperature increased—Idarubicin—hematologic cancer	0.000237	0.00299	CcSEcCtD
Liothyronine—Acute coronary syndrome—Mitoxantrone—hematologic cancer	0.000236	0.00298	CcSEcCtD
Liothyronine—Acute coronary syndrome—Irinotecan—hematologic cancer	0.000236	0.00298	CcSEcCtD
Liothyronine—Hypertension—Vinblastine—hematologic cancer	0.000236	0.00297	CcSEcCtD
Liothyronine—Myocardial infarction—Mitoxantrone—hematologic cancer	0.000235	0.00296	CcSEcCtD
Liothyronine—Myocardial infarction—Irinotecan—hematologic cancer	0.000235	0.00296	CcSEcCtD
Liothyronine—Cardiac failure congestive—Betamethasone—hematologic cancer	0.000234	0.00296	CcSEcCtD
Liothyronine—Cardiac failure congestive—Dexamethasone—hematologic cancer	0.000234	0.00296	CcSEcCtD
Liothyronine—Arrhythmia—Vinorelbine—hematologic cancer	0.000233	0.00294	CcSEcCtD
Liothyronine—Tachycardia—Nilotinib—hematologic cancer	0.000232	0.00293	CcSEcCtD
Liothyronine—Body temperature increased—Teniposide—hematologic cancer	0.000231	0.00291	CcSEcCtD
Liothyronine—Tachycardia—Imatinib—hematologic cancer	0.000231	0.00291	CcSEcCtD
Liothyronine—Acute coronary syndrome—Gemcitabine—hematologic cancer	0.00023	0.0029	CcSEcCtD
Liothyronine—Myocardial infarction—Gemcitabine—hematologic cancer	0.000229	0.00288	CcSEcCtD
Liothyronine—Tachycardia—Cladribine—hematologic cancer	0.000227	0.00286	CcSEcCtD
Liothyronine—Arrhythmia—Thiotepa—hematologic cancer	0.000222	0.0028	CcSEcCtD
Liothyronine—Hypotension—Nilotinib—hematologic cancer	0.000222	0.0028	CcSEcCtD
Liothyronine—Hypotension—Imatinib—hematologic cancer	0.000221	0.00279	CcSEcCtD
Liothyronine—Hypertension—Lenalidomide—hematologic cancer	0.000218	0.00275	CcSEcCtD
Liothyronine—Hypotension—Cladribine—hematologic cancer	0.000217	0.00274	CcSEcCtD
Liothyronine—Arrhythmia—Thalidomide—hematologic cancer	0.000215	0.00271	CcSEcCtD
Liothyronine—Acute coronary syndrome—Cisplatin—hematologic cancer	0.000214	0.0027	CcSEcCtD
Liothyronine—Body temperature increased—Busulfan—hematologic cancer	0.000214	0.0027	CcSEcCtD
Liothyronine—Myocardial infarction—Cisplatin—hematologic cancer	0.000213	0.00269	CcSEcCtD
Liothyronine—Body temperature increased—Procarbazine—hematologic cancer	0.000207	0.00262	CcSEcCtD
Liothyronine—Tachycardia—Melphalan—hematologic cancer	0.000207	0.00261	CcSEcCtD
Liothyronine—Arrhythmia—Carmustine—hematologic cancer	0.000206	0.0026	CcSEcCtD
Liothyronine—Arrhythmia—Alitretinoin—hematologic cancer	0.000205	0.00258	CcSEcCtD
Liothyronine—Cardiac failure congestive—Prednisone—hematologic cancer	0.000204	0.00258	CcSEcCtD
Liothyronine—Body temperature increased—Bexarotene—hematologic cancer	0.000203	0.00257	CcSEcCtD
Liothyronine—Body temperature increased—Dasatinib—hematologic cancer	0.000203	0.00257	CcSEcCtD
Liothyronine—Body temperature increased—Fludarabine—hematologic cancer	0.000203	0.00256	CcSEcCtD
Liothyronine—Arrhythmia—Ifosfamide—hematologic cancer	0.000202	0.00255	CcSEcCtD
Liothyronine—Tachycardia—Lenalidomide—hematologic cancer	0.000201	0.00254	CcSEcCtD
Liothyronine—Hypertension—Bortezomib—hematologic cancer	0.000201	0.00253	CcSEcCtD
Liothyronine—Hypotension—Melphalan—hematologic cancer	0.000198	0.0025	CcSEcCtD
Liothyronine—Acute coronary syndrome—Etoposide—hematologic cancer	0.000196	0.00248	CcSEcCtD
Liothyronine—Hypertension—Vinorelbine—hematologic cancer	0.000196	0.00247	CcSEcCtD
Liothyronine—Myocardial infarction—Etoposide—hematologic cancer	0.000195	0.00246	CcSEcCtD
Liothyronine—Acute coronary syndrome—Prednisolone—hematologic cancer	0.000194	0.00244	CcSEcCtD
Liothyronine—Hypotension—Lenalidomide—hematologic cancer	0.000192	0.00243	CcSEcCtD
Liothyronine—Myocardial infarction—Prednisolone—hematologic cancer	0.000192	0.00243	CcSEcCtD
Liothyronine—Body temperature increased—Chlorambucil—hematologic cancer	0.000192	0.00242	CcSEcCtD
Liothyronine—Arrhythmia—Irinotecan—hematologic cancer	0.000192	0.00242	CcSEcCtD
Liothyronine—Arrhythmia—Mitoxantrone—hematologic cancer	0.000192	0.00242	CcSEcCtD
Liothyronine—Body temperature increased—Nilotinib—hematologic cancer	0.000188	0.00237	CcSEcCtD
Liothyronine—Hypertension—Thiotepa—hematologic cancer	0.000187	0.00236	CcSEcCtD
Liothyronine—Arrhythmia—Gemcitabine—hematologic cancer	0.000187	0.00236	CcSEcCtD
Liothyronine—ABCB1—gonad—hematologic cancer	0.000187	0.00466	CbGeAlD
Liothyronine—Body temperature increased—Imatinib—hematologic cancer	0.000187	0.00236	CcSEcCtD
Liothyronine—Tachycardia—Bortezomib—hematologic cancer	0.000185	0.00233	CcSEcCtD
Liothyronine—Body temperature increased—Cladribine—hematologic cancer	0.000184	0.00232	CcSEcCtD
Liothyronine—Hypertension—Thalidomide—hematologic cancer	0.000181	0.00228	CcSEcCtD
Liothyronine—Tachycardia—Vinorelbine—hematologic cancer	0.000181	0.00228	CcSEcCtD
Liothyronine—Acute coronary syndrome—Triamcinolone—hematologic cancer	0.000178	0.00225	CcSEcCtD
Liothyronine—Hypotension—Bortezomib—hematologic cancer	0.000177	0.00223	CcSEcCtD
Liothyronine—Myocardial infarction—Triamcinolone—hematologic cancer	0.000177	0.00223	CcSEcCtD
Liothyronine—Hypotension—Bleomycin—hematologic cancer	0.000176	0.00222	CcSEcCtD
Liothyronine—Arrhythmia—Cisplatin—hematologic cancer	0.000174	0.0022	CcSEcCtD
Liothyronine—Hypertension—Carmustine—hematologic cancer	0.000174	0.00219	CcSEcCtD
Liothyronine—Hypotension—Vinorelbine—hematologic cancer	0.000173	0.00218	CcSEcCtD
Liothyronine—Tachycardia—Thiotepa—hematologic cancer	0.000172	0.00218	CcSEcCtD
Liothyronine—Hypertension—Alitretinoin—hematologic cancer	0.000172	0.00217	CcSEcCtD
Liothyronine—Hypertension—Ifosfamide—hematologic cancer	0.00017	0.00214	CcSEcCtD
Liothyronine—Phlebitis—Epirubicin—hematologic cancer	0.000168	0.00212	CcSEcCtD
Liothyronine—Tachycardia—Thalidomide—hematologic cancer	0.000167	0.0021	CcSEcCtD
Liothyronine—Hypertension—Vincristine—hematologic cancer	0.000166	0.00209	CcSEcCtD
Liothyronine—Body temperature increased—Lenalidomide—hematologic cancer	0.000163	0.00205	CcSEcCtD
Liothyronine—ABCB1—blood—hematologic cancer	0.000163	0.00406	CbGeAlD
Liothyronine—Acute coronary syndrome—Betamethasone—hematologic cancer	0.000161	0.00204	CcSEcCtD
Liothyronine—Acute coronary syndrome—Dexamethasone—hematologic cancer	0.000161	0.00204	CcSEcCtD
Liothyronine—Hypertension—Mitoxantrone—hematologic cancer	0.000161	0.00204	CcSEcCtD
Liothyronine—Hypertension—Irinotecan—hematologic cancer	0.000161	0.00204	CcSEcCtD
Liothyronine—Myocardial infarction—Dexamethasone—hematologic cancer	0.000161	0.00203	CcSEcCtD
Liothyronine—Myocardial infarction—Betamethasone—hematologic cancer	0.000161	0.00203	CcSEcCtD
Liothyronine—Body temperature increased—Hydroxyurea—hematologic cancer	0.000161	0.00203	CcSEcCtD
Liothyronine—Tachycardia—Carmustine—hematologic cancer	0.00016	0.00202	CcSEcCtD
Liothyronine—Hypotension—Thalidomide—hematologic cancer	0.00016	0.00201	CcSEcCtD
Liothyronine—Cardiac failure congestive—Epirubicin—hematologic cancer	0.00016	0.00201	CcSEcCtD
Liothyronine—Tachycardia—Alitretinoin—hematologic cancer	0.000159	0.002	CcSEcCtD
Liothyronine—ABCB1—bone marrow—hematologic cancer	0.000158	0.00393	CbGeAlD
Liothyronine—Arrhythmia—Prednisolone—hematologic cancer	0.000157	0.00199	CcSEcCtD
Liothyronine—Hypertension—Gemcitabine—hematologic cancer	0.000157	0.00198	CcSEcCtD
Liothyronine—Phlebitis—Doxorubicin—hematologic cancer	0.000156	0.00196	CcSEcCtD
Liothyronine—Hypotension—Carmustine—hematologic cancer	0.000153	0.00194	CcSEcCtD
Liothyronine—Hypotension—Alitretinoin—hematologic cancer	0.000152	0.00192	CcSEcCtD
Liothyronine—Hypotension—Ifosfamide—hematologic cancer	0.00015	0.00189	CcSEcCtD
Liothyronine—Body temperature increased—Bortezomib—hematologic cancer	0.00015	0.00189	CcSEcCtD
Liothyronine—Tachycardia—Mitoxantrone—hematologic cancer	0.000149	0.00188	CcSEcCtD
Liothyronine—Body temperature increased—Bleomycin—hematologic cancer	0.000149	0.00188	CcSEcCtD
Liothyronine—Cardiac failure congestive—Doxorubicin—hematologic cancer	0.000148	0.00186	CcSEcCtD
Liothyronine—Hypotension—Vincristine—hematologic cancer	0.000146	0.00185	CcSEcCtD
Liothyronine—Body temperature increased—Vinorelbine—hematologic cancer	0.000146	0.00185	CcSEcCtD
Liothyronine—Arrhythmia—Triamcinolone—hematologic cancer	0.000145	0.00183	CcSEcCtD
Liothyronine—ABCB1—lung—hematologic cancer	0.000143	0.00356	CbGeAlD
Liothyronine—Hypotension—Irinotecan—hematologic cancer	0.000143	0.0018	CcSEcCtD
Liothyronine—Hypotension—Mitoxantrone—hematologic cancer	0.000143	0.0018	CcSEcCtD
Liothyronine—Acute coronary syndrome—Prednisone—hematologic cancer	0.000141	0.00177	CcSEcCtD
Liothyronine—Myocardial infarction—Prednisone—hematologic cancer	0.00014	0.00176	CcSEcCtD
Liothyronine—Body temperature increased—Thiotepa—hematologic cancer	0.00014	0.00176	CcSEcCtD
Liothyronine—Hypotension—Gemcitabine—hematologic cancer	0.000139	0.00175	CcSEcCtD
Liothyronine—Tachycardia—Cisplatin—hematologic cancer	0.000135	0.00171	CcSEcCtD
Liothyronine—Body temperature increased—Thalidomide—hematologic cancer	0.000135	0.0017	CcSEcCtD
Liothyronine—ABCB1—testis—hematologic cancer	0.000135	0.00336	CbGeAlD
Liothyronine—Hypertension—Etoposide—hematologic cancer	0.000134	0.00169	CcSEcCtD
Liothyronine—Hypertension—Prednisolone—hematologic cancer	0.000132	0.00167	CcSEcCtD
Liothyronine—Arrhythmia—Dexamethasone—hematologic cancer	0.000131	0.00166	CcSEcCtD
Liothyronine—Arrhythmia—Betamethasone—hematologic cancer	0.000131	0.00166	CcSEcCtD
Liothyronine—Body temperature increased—Carmustine—hematologic cancer	0.00013	0.00164	CcSEcCtD
Liothyronine—Hypotension—Cisplatin—hematologic cancer	0.000129	0.00163	CcSEcCtD
Liothyronine—Body temperature increased—Alitretinoin—hematologic cancer	0.000129	0.00162	CcSEcCtD
Liothyronine—Body temperature increased—Ifosfamide—hematologic cancer	0.000127	0.0016	CcSEcCtD
Liothyronine—Tachycardia—Etoposide—hematologic cancer	0.000124	0.00156	CcSEcCtD
Liothyronine—Body temperature increased—Vincristine—hematologic cancer	0.000124	0.00156	CcSEcCtD
Liothyronine—Levothyroxine—ALB—hematologic cancer	0.000123	0.0562	CrCbGaD
Liothyronine—Tachycardia—Prednisolone—hematologic cancer	0.000122	0.00154	CcSEcCtD
Liothyronine—Angina pectoris—Epirubicin—hematologic cancer	0.000122	0.00154	CcSEcCtD
Liothyronine—Hypertension—Triamcinolone—hematologic cancer	0.000122	0.00154	CcSEcCtD
Liothyronine—Body temperature increased—Mitoxantrone—hematologic cancer	0.000121	0.00152	CcSEcCtD
Liothyronine—Body temperature increased—Irinotecan—hematologic cancer	0.000121	0.00152	CcSEcCtD
Liothyronine—Liotrix—ALB—hematologic cancer	0.00012	0.0548	CrCbGaD
Liothyronine—Hypotension—Etoposide—hematologic cancer	0.000119	0.0015	CcSEcCtD
Liothyronine—Levothyroxine—ABCB1—hematologic cancer	0.000118	0.0536	CrCbGaD
Liothyronine—Body temperature increased—Gemcitabine—hematologic cancer	0.000118	0.00148	CcSEcCtD
Liothyronine—Liotrix—ABCB1—hematologic cancer	0.000115	0.0523	CrCbGaD
Liothyronine—Arrhythmia—Prednisone—hematologic cancer	0.000114	0.00144	CcSEcCtD
Liothyronine—Angina pectoris—Doxorubicin—hematologic cancer	0.000113	0.00142	CcSEcCtD
Liothyronine—Tachycardia—Triamcinolone—hematologic cancer	0.000112	0.00142	CcSEcCtD
Liothyronine—Hypertension—Dexamethasone—hematologic cancer	0.000111	0.00139	CcSEcCtD
Liothyronine—Hypertension—Betamethasone—hematologic cancer	0.000111	0.00139	CcSEcCtD
Liothyronine—Body temperature increased—Cisplatin—hematologic cancer	0.00011	0.00138	CcSEcCtD
Liothyronine—SLC7A5—Desoximetasone—Betamethasone—hematologic cancer	0.000103	0.0514	CbGdCrCtD
Liothyronine—SLC7A5—Desoximetasone—Dexamethasone—hematologic cancer	0.000103	0.0514	CbGdCrCtD
Liothyronine—Tachycardia—Betamethasone—hematologic cancer	0.000102	0.00129	CcSEcCtD
Liothyronine—Tachycardia—Dexamethasone—hematologic cancer	0.000102	0.00129	CcSEcCtD
Liothyronine—SLC7A5—Desoximetasone—Triamcinolone—hematologic cancer	0.0001	0.0502	CbGdCrCtD
Liothyronine—Body temperature increased—Etoposide—hematologic cancer	0.0001	0.00127	CcSEcCtD
Liothyronine—Hypotension—Dexamethasone—hematologic cancer	9.76e-05	0.00123	CcSEcCtD
Liothyronine—Hypotension—Betamethasone—hematologic cancer	9.76e-05	0.00123	CcSEcCtD
Liothyronine—ABCB1—lymph node—hematologic cancer	9.76e-05	0.00243	CbGeAlD
Liothyronine—Hypertension—Prednisone—hematologic cancer	9.63e-05	0.00121	CcSEcCtD
Liothyronine—SLC7A5—Desoximetasone—Prednisone—hematologic cancer	9.53e-05	0.0477	CbGdCrCtD
Liothyronine—SLC7A5—Desoximetasone—Prednisolone—hematologic cancer	9.3e-05	0.0465	CbGdCrCtD
Liothyronine—Body temperature increased—Triamcinolone—hematologic cancer	9.1e-05	0.00115	CcSEcCtD
Liothyronine—Arrhythmia—Epirubicin—hematologic cancer	8.95e-05	0.00113	CcSEcCtD
Liothyronine—Tachycardia—Prednisone—hematologic cancer	8.88e-05	0.00112	CcSEcCtD
Liothyronine—Arrhythmia—Doxorubicin—hematologic cancer	8.28e-05	0.00104	CcSEcCtD
Liothyronine—Body temperature increased—Dexamethasone—hematologic cancer	8.26e-05	0.00104	CcSEcCtD
Liothyronine—Body temperature increased—Betamethasone—hematologic cancer	8.26e-05	0.00104	CcSEcCtD
Liothyronine—Hypertension—Epirubicin—hematologic cancer	7.53e-05	0.00095	CcSEcCtD
Liothyronine—Body temperature increased—Prednisone—hematologic cancer	7.19e-05	0.000907	CcSEcCtD
Liothyronine—Hypotension—Methotrexate—hematologic cancer	7.11e-05	0.000896	CcSEcCtD
Liothyronine—Hypertension—Doxorubicin—hematologic cancer	6.97e-05	0.000879	CcSEcCtD
Liothyronine—Tachycardia—Epirubicin—hematologic cancer	6.95e-05	0.000876	CcSEcCtD
Liothyronine—Hypotension—Epirubicin—hematologic cancer	6.65e-05	0.000839	CcSEcCtD
Liothyronine—Tachycardia—Doxorubicin—hematologic cancer	6.43e-05	0.000811	CcSEcCtD
Liothyronine—Hypotension—Doxorubicin—hematologic cancer	6.15e-05	0.000776	CcSEcCtD
Liothyronine—Body temperature increased—Methotrexate—hematologic cancer	6.01e-05	0.000758	CcSEcCtD
Liothyronine—Body temperature increased—Epirubicin—hematologic cancer	5.63e-05	0.00071	CcSEcCtD
Liothyronine—Body temperature increased—Doxorubicin—hematologic cancer	5.21e-05	0.000657	CcSEcCtD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	4.77e-06	6.42e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	4.76e-06	6.4e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—IDH2—hematologic cancer	4.73e-06	6.37e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HMMR—hematologic cancer	4.73e-06	6.37e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PIK3CB—hematologic cancer	4.7e-06	6.33e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—EP300—hematologic cancer	4.68e-06	6.3e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—JAK1—hematologic cancer	4.68e-06	6.29e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PRKCG—hematologic cancer	4.68e-06	6.29e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	4.61e-06	6.21e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	4.6e-06	6.19e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MAP2K1—hematologic cancer	4.59e-06	6.18e-05	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.59e-06	6.17e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—MTHFR—hematologic cancer	4.57e-06	6.15e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PIK3CD—hematologic cancer	4.56e-06	6.14e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—SRC—hematologic cancer	4.55e-06	6.12e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NQO1—hematologic cancer	4.54e-06	6.1e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CD44—hematologic cancer	4.54e-06	6.1e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	4.5e-06	6.06e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.49e-06	6.04e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.46e-06	6e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—FHL2—hematologic cancer	4.46e-06	6e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ARNTL—hematologic cancer	4.45e-06	5.98e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.44e-06	5.98e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GSTP1—hematologic cancer	4.43e-06	5.95e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	4.39e-06	5.91e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—STAT3—hematologic cancer	4.39e-06	5.9e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—NRAS—hematologic cancer	4.38e-06	5.89e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—AGRN—hematologic cancer	4.37e-06	5.88e-05	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.37e-06	5.88e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—FGF2—hematologic cancer	4.37e-06	5.88e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IL2RA—hematologic cancer	4.37e-06	5.88e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	4.33e-06	5.83e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CA9—hematologic cancer	4.33e-06	5.82e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ACP5—hematologic cancer	4.33e-06	5.82e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PIK3R1—hematologic cancer	4.31e-06	5.8e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CYCS—hematologic cancer	4.29e-06	5.78e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.28e-06	5.76e-05	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—AKT1—hematologic cancer	4.27e-06	5.75e-05	CbGpPWpGaD
Liothyronine—THRB—Gene Expression—AKT1—hematologic cancer	4.27e-06	5.75e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOR2—hematologic cancer	4.27e-06	5.75e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	4.27e-06	5.74e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—HSP90AA1—hematologic cancer	4.27e-06	5.74e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	4.22e-06	5.68e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PDGFB—hematologic cancer	4.22e-06	5.67e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—MAPK3—hematologic cancer	4.19e-06	5.64e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—ABCB1—hematologic cancer	4.19e-06	5.64e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—JAK2—hematologic cancer	4.19e-06	5.63e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	4.16e-06	5.59e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—IDH2—hematologic cancer	4.15e-06	5.58e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HMMR—hematologic cancer	4.15e-06	5.58e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—CDK2—hematologic cancer	4.09e-06	5.5e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MDM2—hematologic cancer	4.09e-06	5.5e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—MYC—hematologic cancer	4.08e-06	5.49e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—IDH1—hematologic cancer	4.07e-06	5.47e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—TGFB1—hematologic cancer	4.07e-06	5.47e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GSTM1—hematologic cancer	4.07e-06	5.47e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NCOR1—hematologic cancer	4.07e-06	5.47e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PTEN—hematologic cancer	4.06e-06	5.47e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.03e-06	5.42e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ABCC3—hematologic cancer	4.02e-06	5.41e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—TXN—hematologic cancer	4.02e-06	5.41e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTO1—hematologic cancer	4.02e-06	5.41e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	3.99e-06	5.37e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MTOR—hematologic cancer	3.98e-06	5.35e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PIK3CB—hematologic cancer	3.98e-06	5.35e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SPHK1—hematologic cancer	3.94e-06	5.3e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.93e-06	5.29e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—MAPK14—hematologic cancer	3.92e-06	5.28e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ARNTL—hematologic cancer	3.9e-06	5.24e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—EP300—hematologic cancer	3.88e-06	5.21e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	3.88e-06	5.21e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CG—hematologic cancer	3.84e-06	5.17e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.84e-06	5.17e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	3.83e-06	5.15e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	3.82e-06	5.13e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—FN1—hematologic cancer	3.8e-06	5.12e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ACP5—hematologic cancer	3.79e-06	5.1e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CA9—hematologic cancer	3.79e-06	5.1e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTP1—hematologic cancer	3.78e-06	5.09e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—UGT1A1—hematologic cancer	3.78e-06	5.09e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—KRAS—hematologic cancer	3.77e-06	5.07e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOR2—hematologic cancer	3.74e-06	5.03e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CDKN1B—hematologic cancer	3.73e-06	5.02e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CRABP1—hematologic cancer	3.68e-06	4.95e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SLC22A1—hematologic cancer	3.68e-06	4.95e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.66e-06	4.93e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CASP3—hematologic cancer	3.66e-06	4.92e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IL2—hematologic cancer	3.65e-06	4.91e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CG—hematologic cancer	3.64e-06	4.9e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—MTHFR—hematologic cancer	3.59e-06	4.84e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ALOX5—hematologic cancer	3.59e-06	4.82e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ABCB1—hematologic cancer	3.58e-06	4.82e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PTPN11—hematologic cancer	3.58e-06	4.81e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—IDH1—hematologic cancer	3.56e-06	4.8e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—CREBBP—hematologic cancer	3.56e-06	4.79e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	3.56e-06	4.79e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CCND1—hematologic cancer	3.56e-06	4.79e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—JUN—hematologic cancer	3.55e-06	4.78e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	3.53e-06	4.75e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—TXN—hematologic cancer	3.53e-06	4.74e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ABCC3—hematologic cancer	3.53e-06	4.74e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTO1—hematologic cancer	3.53e-06	4.74e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NCOR1—hematologic cancer	3.48e-06	4.68e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTM1—hematologic cancer	3.48e-06	4.68e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NUP98—hematologic cancer	3.47e-06	4.67e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—PIK3CA—hematologic cancer	3.46e-06	4.66e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SPHK1—hematologic cancer	3.45e-06	4.64e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CDKN1A—hematologic cancer	3.44e-06	4.63e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PTEN—hematologic cancer	3.44e-06	4.62e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	3.38e-06	4.55e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—CREBBP—hematologic cancer	3.37e-06	4.54e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ADCY7—hematologic cancer	3.37e-06	4.54e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOA3—hematologic cancer	3.37e-06	4.54e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MAPK8—hematologic cancer	3.36e-06	4.52e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NUP214—hematologic cancer	3.35e-06	4.5e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—ALB—hematologic cancer	3.34e-06	4.49e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—UGT1A1—hematologic cancer	3.31e-06	4.46e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.31e-06	4.46e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	3.3e-06	4.44e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ABCG2—hematologic cancer	3.28e-06	4.41e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—MTR—hematologic cancer	3.28e-06	4.41e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—EP300—hematologic cancer	3.28e-06	4.41e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	3.25e-06	4.37e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SLC22A1—hematologic cancer	3.22e-06	4.34e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CRABP1—hematologic cancer	3.22e-06	4.34e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ENO2—hematologic cancer	3.22e-06	4.33e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—HRAS—hematologic cancer	3.2e-06	4.31e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CD—hematologic cancer	3.2e-06	4.3e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	3.19e-06	4.29e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—SRC—hematologic cancer	3.19e-06	4.29e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.17e-06	4.26e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ALOX5—hematologic cancer	3.14e-06	4.23e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	3.14e-06	4.23e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTT1—hematologic cancer	3.12e-06	4.2e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—VEGFA—hematologic cancer	3.1e-06	4.18e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—MTHFR—hematologic cancer	3.07e-06	4.13e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—STAT3—hematologic cancer	3.07e-06	4.13e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.07e-06	4.13e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—NRAS—hematologic cancer	3.07e-06	4.12e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—IL6—hematologic cancer	3.07e-06	4.12e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SDC1—hematologic cancer	3.05e-06	4.1e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NUP98—hematologic cancer	3.04e-06	4.09e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3R1—hematologic cancer	3.02e-06	4.06e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	3.02e-06	4.06e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ADCY7—hematologic cancer	2.95e-06	3.97e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOA3—hematologic cancer	2.95e-06	3.97e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	2.95e-06	3.96e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MAPK3—hematologic cancer	2.94e-06	3.95e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—JAK2—hematologic cancer	2.94e-06	3.95e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NUP214—hematologic cancer	2.93e-06	3.95e-05	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.92e-06	3.93e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.91e-06	3.92e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—MTR—hematologic cancer	2.87e-06	3.87e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ABCG2—hematologic cancer	2.87e-06	3.87e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PIK3CA—hematologic cancer	2.87e-06	3.86e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MYC—hematologic cancer	2.86e-06	3.84e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TGFB1—hematologic cancer	2.85e-06	3.83e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—AKT1—hematologic cancer	2.83e-06	3.8e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ENO2—hematologic cancer	2.82e-06	3.79e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CREBBP—hematologic cancer	2.8e-06	3.77e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CB—hematologic cancer	2.79e-06	3.75e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.75e-06	3.7e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTT1—hematologic cancer	2.73e-06	3.68e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.71e-06	3.64e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	2.69e-06	3.62e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SDC1—hematologic cancer	2.67e-06	3.59e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—KRAS—hematologic cancer	2.64e-06	3.55e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—ALB—hematologic cancer	2.62e-06	3.53e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NQO1—hematologic cancer	2.59e-06	3.49e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CD44—hematologic cancer	2.59e-06	3.49e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	2.58e-06	3.47e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IL2—hematologic cancer	2.56e-06	3.45e-05	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.56e-06	3.44e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PTEN—hematologic cancer	2.54e-06	3.42e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.54e-06	3.42e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	2.51e-06	3.37e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYCS—hematologic cancer	2.45e-06	3.3e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HSP90AA1—hematologic cancer	2.44e-06	3.28e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—EP300—hematologic cancer	2.43e-06	3.26e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PIK3CA—hematologic cancer	2.42e-06	3.26e-05	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.4e-06	3.22e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CREBBP—hematologic cancer	2.39e-06	3.22e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TP53—hematologic cancer	2.35e-06	3.16e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—AKT1—hematologic cancer	2.34e-06	3.15e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	2.31e-06	3.11e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—EP300—hematologic cancer	2.3e-06	3.09e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CD44—hematologic cancer	2.27e-06	3.06e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NQO1—hematologic cancer	2.27e-06	3.06e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.27e-06	3.05e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—HRAS—hematologic cancer	2.24e-06	3.02e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ALB—hematologic cancer	2.24e-06	3.01e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—SRC—hematologic cancer	2.23e-06	3.01e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.19e-06	2.95e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—VEGFA—hematologic cancer	2.18e-06	2.93e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTP1—hematologic cancer	2.16e-06	2.91e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—NRAS—hematologic cancer	2.15e-06	2.89e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYCS—hematologic cancer	2.15e-06	2.89e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IL6—hematologic cancer	2.15e-06	2.89e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.14e-06	2.88e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.14e-06	2.87e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.09e-06	2.81e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—MAPK3—hematologic cancer	2.06e-06	2.77e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ABCB1—hematologic cancer	2.05e-06	2.75e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PTEN—hematologic cancer	2e-06	2.69e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TGFB1—hematologic cancer	2e-06	2.69e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOR1—hematologic cancer	1.99e-06	2.67e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTM1—hematologic cancer	1.99e-06	2.67e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—AKT1—hematologic cancer	1.98e-06	2.66e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	1.98e-06	2.66e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—EP300—hematologic cancer	1.91e-06	2.57e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTP1—hematologic cancer	1.89e-06	2.55e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—KRAS—hematologic cancer	1.85e-06	2.49e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	1.8e-06	2.42e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—MTHFR—hematologic cancer	1.76e-06	2.36e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOR1—hematologic cancer	1.74e-06	2.34e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTM1—hematologic cancer	1.74e-06	2.34e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.71e-06	2.3e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CA—hematologic cancer	1.7e-06	2.29e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TP53—hematologic cancer	1.64e-06	2.21e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—EP300—hematologic cancer	1.63e-06	2.19e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—HRAS—hematologic cancer	1.57e-06	2.12e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.55e-06	2.08e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—MTHFR—hematologic cancer	1.54e-06	2.07e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CG—hematologic cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—AKT1—hematologic cancer	1.47e-06	1.97e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.41e-06	1.9e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—AKT1—hematologic cancer	1.39e-06	1.87e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CREBBP—hematologic cancer	1.37e-06	1.84e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CD—hematologic cancer	1.3e-06	1.74e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.29e-06	1.74e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3R1—hematologic cancer	1.22e-06	1.65e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.21e-06	1.62e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.2e-06	1.61e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.15e-06	1.55e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.14e-06	1.53e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CB—hematologic cancer	1.13e-06	1.52e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ALB—hematologic cancer	1.12e-06	1.51e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.07e-06	1.44e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CB—hematologic cancer	9.91e-07	1.33e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—AKT1—hematologic cancer	9.85e-07	1.33e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTEN—hematologic cancer	9.77e-07	1.31e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—EP300—hematologic cancer	9.32e-07	1.25e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTEN—hematologic cancer	8.56e-07	1.15e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—EP300—hematologic cancer	8.16e-07	1.1e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CA—hematologic cancer	6.89e-07	9.27e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CA—hematologic cancer	6.04e-07	8.12e-06	CbGpPWpGaD
Liothyronine—ALB—Metabolism—AKT1—hematologic cancer	5.63e-07	7.57e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—AKT1—hematologic cancer	4.93e-07	6.64e-06	CbGpPWpGaD
